A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
A Multicenter Clinical Trial to Compare the Efficacy and Safety Between Rosuvastatin/Ezetimibe Combination and Monotherapy of Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
Sponsor: Linical Korea
Listed as NCT03217409, this PHASE4 trial focuses on Diabetes Mellitus and Hypercholesterolemia and remains completed. Sponsored by Linical Korea, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Oct 2019 — Jan 2021 [monthly]
Completed PHASE4
Status: Recruiting → Completed
▶ Show 4 earlier versions
-
May 2019 — Oct 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Feb 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Linical Korea
- Yuhan Corporation
For direct contact, visit the study record on ClinicalTrials.gov .